Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Recent Jerini patent describes novel therapeutic agents for eye, skin and joint disorders

Nov. 10, 2005

Novartis signs agreement for glaucoma treatment Y-39983

Nov. 10, 2005

A second phase III study confirms the therapeutic benefits of ranibizumab in AMD

Nov. 9, 2005

OT-551 begins phase II trial in cataract prevention

Nov. 9, 2005

Fovea completes Series A financing to develop drugs for retinal diseases

Nov. 9, 2005

Pegaptanib improves visual acuity in patients with diabetic macular edema

Oct. 27, 2005

Clinical evidence supports the use of Evizon in wet AMD

Oct. 26, 2005

Bevacizumab improves visual acuity of patients with neovascular AMD

Oct. 26, 2005

Method to predict/detect age-related macular degeneration reported by the University of Iowa

Oct. 26, 2005

Infliximab shows promise in the treatment of refractory PUK

Oct. 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...